DAWN FRENCH: Open Payments
NPI 1124358254 · ALLIANCE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,125 in 110 payments from 17 companies in 2025. Trend: 2023 $7,134 · 2024 $8,402 · 2025 $4,125
Speaker / faculty: $2,400Food & beverage: $1,671Education: $54
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 11 | $2,497 |
| ABBVIE INC. | 49 | $609 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $191 |
| Janssen Biotech, Inc. | 9 | $178 |
| GENZYME CORPORATION | 3 | $121 |
| Gilead Sciences, Inc. | 4 | $112 |
| Ipsen Biopharmaceuticals, Inc | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Madrigal Pharmaceuticals | 3 | $68 |
| Lilly USA, LLC | 2 | $48 |
Products named: ZENPEP, RINVOQ, XIFAXAN, DUPIXENT, TREMFYA, CREON, LINZESS, SKYRIZI.
Industry payments across OH — which companies pay providers there.
